White paper

Decoding biosimilar strategies: Key US payer trends for 2025

  • headshot

    Shaila Yoshida

  • Tasmina Hydery

    Tasmina Hydery

Stay ahead in the rapidly evolving biosimilar landscape with this comprehensive report exploring key trends shaping the U.S. payer environment. Based on insights from 51 payer decision-makers representing over 271 million PBM lives, this report delves into the factors driving biosimilar adoption, payer strategies for coverage, and the challenges and opportunities in managing pharmacy benefit biosimilars. Learn how biosimilars are transforming healthcare by offering cost-effective alternatives and uncover how payers are navigating pricing dynamics, formulary placement, and utilization management tools.

Key highlights:

  • Trends in payer strategies for biosimilar coverage and contracting
  • Factors driving biosimilar adoption and addressing barriers to uptake
  • The role of pricing dynamics, rebates, and policy changes in influencing coverage decisions
  • Insights into innovative programs increasing biosimilar access and affordability
  • Future outlook for biosimilars, including the adoption of ustekinumab biosimilars

Discover how payers are shaping the future of biosimilars and what it means for healthcare stakeholders.
Biosimilars pdf preview

Access the white paper

Pardot Form

Connect with our team

Our commitment to helping clients achieve market access plays a crucial role in patients’ access to affordable, diverse, and effective therapies so they can achieve their best potential health outcomes. Connect with our team of experts to discover how we can help support your goals.

Related resources

Business meeting with 4 participants.

Report

FDA programs on the horizon: What biopharma companies need to know
Learn more
'"

Guide

Five strategic shifts to lead pharma through change
Learn more
HTA Quarterly

Article

HTA Quarterly Fall 2025 Summary
Learn more

Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.

Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.